CURRENT NEWS

• 03.04.2020
  MOFCOM, China Expands the Investigation Period of Methionine Anti-Dumping Case by Six Months
• 03.04.2020
  Persistent Systems Contributing Rs. 25 Crores ($3.3M) in Support of COVID-19 Efforts Globally
• 03.04.2020
  Disclosure Under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
• 03.04.2020
  FHI Clinical Providing Full-Service CRO Capabilities for Coronavirus (COVID-19) Clinical Trial
• 03.04.2020
  Spectrum Solutions Saliva Collection Device Answers Critical Testing Hurdles, Enabling Large-Scale COVID-19 Testing While Protecting Health Professionals From Exposure
• 03.04.2020
  Aptar Requests U.S. FDA Emergency Use Authorization for N95 Filtering Facepiece Respirator Decontamination With ActivShield
• 03.04.2020
  Neuraxpharm Launches the Social Initiative "Quarantine Together"
• 03.04.2020
  South Carolina Laboratory Launching Effort to Supply Free COVID-19 Tests to First Responders
• 03.04.2020
  Eurofins' U.S. Clinical Diagnostics Network Launches Coronavirus (COVID-19) Antibody Testing
• 03.04.2020
  COVID-19 Antibody Test Released by Ortho Clinical Diagnostics
• 03.04.2020
  BD, BioGX Announce FDA Emergency Use Authorization for New COVID-19 Diagnostic for Use in U.S
• 03.04.2020
  BIOTECON Diagnostics Enters Into Exclusive Distribution Agreement to Supply Coronavirus Detection Tests to Most Markets Worldwide
• 03.04.2020
  Aperiomics Increases COVID-19 Testing Capacity With Equipment and Volunteer Support From Janelia Research Campus
• 03.04.2020
  Leica Biosystems Receives FDA's Enforcement Discretion for Use of Aperio ImageScope DX Viewing Software for Remote Diagnosis During COVID-19 Emergency
• 03.04.2020
  Questcap Signs Binding LOI to Acquire Interest in Amino Therapeutics
• 03.04.2020
  Predictive Technology Group Announces Distribution Agreement With Wellgistics, LLC for Its Assurance AB COVID-19 IgM/IgG Rapid Antibody Test for Use by Laboratories and Healthcare Workers at the Point-Of-Care
• 03.04.2020
  Oncology Venture Draws Down the First Tranche Under Its Convertible Note Agreement With Negma Group LTD and Park Partners GB
• 03.04.2020
  Servier Signed a Definitive Agreement to Acquire Symphogen, a Leading Antibody Discovery Company, to Boost Its Antibody Capabilities and Leverage Its R&D Pipeline
• 03.04.2020
  Syneos Health Responds to COVID-19 Public Health Challenge by Joining Call to Action to Activate Clinically-Qualified Healthcare Professionals
• 03.04.2020
  XBiotech and BioBridge Global Collaborate on FDA Program to Develop Potential COVID-19 Treatment Based on Natural Antibodies From Recovered Patients

Records per page:

Page

Total: 17904 records.